← All candidates
184 insider filings on record.
184 filings on record.
KRYSKrystal Biotech, Inc.
NasdaqGS · Healthcare · $9.97B
$336.68
-2.01% · Sep 14
184 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 122 sells
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$9.97B
Float
23.6M
80% public
Short % float
Pro
Price / profit
42.6
Price / future profit
35.8
Price / sales
22.6
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
179 more transactions on Pro →Context
Wall St
$328.44 avg target
-2.4% vs today · 9 analysts · consensus Strong Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
3 of 4 quarters beat
Q1 '26$1.83 act+$0.41
Q4 '25$1.70 act+$0.09
Q3 '25$2.66 act+$1.54
Q2 '25$1.29 act−$0.15
Coverage
Is Krystal Biotech, Inc. (KRYS) A Good Stock To Buy Now?Insider Monkey · 06-07Is the Options Market Predicting a Spike in Krystal Biotech Stock?Zacks · 06-05These Are 5 Of The Best Stocks To Buy Or Watch NowInvestor's Business Daily · 06-15Exploring 3 High Growth Tech Stocks in US MarketSimply Wall St. · 06-15
The file stays open
184 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice